Back to search
FDAFDA · Food and drugs·Recall number D-0173-2021

Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15.

Published December 9, 2020 · Recall initiated: November 24, 2020

Summary

FDA records drug Class II recall D-0173-2021, published December 9, 2020 and initiated November 24, 2020. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 1200 bottles; Lot: Lot #19143017, Exp. 05/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; Out of Specification (low) results were obtained.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if TIZANIDINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TIZANIDINE
Manufacturer
Ascend Laboratories LLC
Distributor
MI
Lot
Lot #19143017, Exp. 05/31/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15. recalled?

Yes. FDA published recall D-0173-2021 on December 9, 2020. Reported hazard: Failed Dissolution Specifications; Out of Specification (low) results were obtained.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TIZANIDINE.